Growth momentum OPEN Health is expanding leadership and client experience capabilities in 2026 with hires in patient experience, global client partnerships, operations leadership, and people strategy. This indicates a maturation of their global delivery model and potential demand for enhanced program management, change management, and cross-border compliance services to support scaled implementations.

Strategic partnerships Recent and ongoing partnerships such as with the LUNGevity Foundation signal a focus on patient-centric outcomes and collaboration with patient advocacy groups. This presents opportunities to offer patient engagement analytics, real-world evidence solutions, and patient pathway optimization services to biopharma clients seeking value demonstration and compassionate access programs.

Tech-enabled services The tech stack includes analytics and collaboration tools like Tableau, Jira, and Microsoft Defender, alongside website and process tooling. This suggests potential to upsell advanced HEOR and market access offerings that leverage data visualization, workflow orchestration, and security-focused delivery, targeting clients seeking scalable, tech-enabled insight platforms.

Market positioning Operating in research services with a revenue range of 1M to 10M and a compact team size positions OPEN Health as a boutique, high-value partner for mid-market biopharma. There is an opportunity to target medium-sized pharma and biotech firms seeking integrated medical affairs and market access solutions with global reach.

Global capability lift Recent hires across New York and London and a stated aim to scale global capabilities imply readiness to support multi-region programs and complex decisions. This creates sales opportunities for global programs, regulatory- and payer-strategy convergence, and end-to-end HEOR and market access services across markets.